Skip to content
Research Article Open access CC BY 3.0

Renoprotective Effect of Sitagliptin ( Dipeptidyl Peptidase- 4 Inhibitor) aganist Cisplatin Induced Nephrotoxicity in Mice

Amany shalaby, Hala Abdel Malek

Journal of Pharmaceutical Research International · pp. 1116–1129 · Published 21 Apr 2014

10.9734/BJPR/2014/9297

Abstract

Back Ground and Objectives: Despite the therapeutic benefits of cisplatin (CDDP), its use clinically is often limited due to dose-related nephrotoxicity. On the meanwhile, DPP 4 inhibitors could attenuate kidney injury, so in the present work, it was aimed to investigate the effect of one of DPP 4 inhibitors (sitagliptin) on cisplatin induced nephrotoxicity in mice. Materials and Methods: 48 male balb-c mice were equally divided into 4 groups, control, sitagliptin group, cisplatin group and cisplatin plus sitagliptin group. The mice were sacrificed at 72h after cisplatin injection. Blood urea nitrogen (BUN) & serum creatinine, renal tissue of antioxidant enzymes, lipid peroxidation, TNF-alpha (TNF-α) were measured as well as histopathological scoring of renal injury. Results: The results demonstrated that sitagliptin significantly ameliorated the nephrotoxic effect of cisplatin with increased activity of antioxidant enzymes, improved kidney function, renal histopathological scoring and decreased tissue level of TNF-α. Conclusions: It can be concluded that sitagliptin may play a protective effect against cisplatin induced acute nephrotoxicity via antioxidant and anti-inflammatory pathway.

Sitaglipin cisplatin nephrotoxicity TNF-alpha antioxidants

References (44)

  1. 1 PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT [DOI]
  2. 2 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction [DOI]
  3. 3 Atherosclerosis — An Inflammatory Disease [DOI]
  4. 4 Selenium: Biochemical Role as a Component of Glutathione Peroxidase [DOI]
  5. 5 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance [DOI]
  6. 6 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [DOI]
  7. 7 Biology of Incretins: GLP-1 and GIP [DOI]
  8. 8 A modified spectrophotometric assay of superoxide dismutase.
  9. 9 Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides [DOI]
  10. 10 TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity [DOI]
  11. 11 GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice [DOI]
  12. 12 Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 [DOI]
  13. 13 The severe cardiorenal syndrome: ‘Guyton revisited’ [DOI]
  14. 14 Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions [DOI]
  15. 15 Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury [DOI]
  16. 16 Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes [DOI]
  17. 17 Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats [DOI]
  18. 18 The effect of sodium nitrite on red cell GSH [DOI]
  19. 19 Manganese Superoxide Dismutase Attenuates Cisplatin-Induced Renal Injury [DOI]
  20. 20 Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice [DOI]
  21. 21 Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death [DOI]
  22. 22 Naringenin attenuates cisplatin nephrotoxicity in rats [DOI]
  23. 23 Serum Interleukin-18 Levels Are Associated With Nephropathy and Atherosclerosis in Japanese Patients With Type 2 Diabetes [DOI]
  24. 24 Long-Term Treatment of Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Diabetic Nephropathy through Improving Metabolic Anomalies in db/db Mice [DOI]
  25. 25 Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats [DOI]
  26. 26 Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells [DOI]
  27. 27 Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat) [DOI]
  28. 28 A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo [DOI]
  29. 29 DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury [DOI]
  30. 30 Effects of glucagon-like peptide-1 receptor agonists on renal function [DOI]
  31. 31 Long-term effects of chemotherapy in patients with testicular cancer. [DOI]
  32. 32 Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody [DOI]
  33. 33 Butein Ameliorates Renal Concentrating Ability in Cisplatin-Induced Acute Renal Failure in Rats [DOI]
  34. 34 Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection [DOI]
  35. 35 Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter [DOI]
  36. 36 CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation [DOI]
  37. 37 A Novel Peptide Nanomedicine Against Acute Lung Injury: GLP-1 in Phospholipid Micelles [DOI]
  38. 38 Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells [DOI]
  39. 39 Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity [DOI]
  40. 40 Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. [DOI]
  41. 41 Intracellular cysteine and glutathione delivery systems. [DOI]
  42. 42 Primary Graft Dysfunction in Lung Transplantation: The Role of CD26/Dipeptidylpeptidase IV and Vasoactive Intestinal Peptide [DOI]
  43. 43 Glucagon-like peptide-1 attenuates tumour necrosis factor-α-mediated induction of plasmogen activator inhibitor-1 expression [DOI]
  44. 44 The Severe Cardiorenal Syndrome

Cited by 6

Effect of sitagliptin, a DPP‐4 inhibitor, against DENA‐induced liver cancer in rats mediated via NF‐κB activation and inflammatory cytokines

Wei-Dong Jiang, Dacheng Wen, Zhaohua Cheng · Journal of biochemical and molecular toxicology · 2018

Sitagliptin exerts anti-apoptotic effect in nephrotoxicity induced by cisplatin in rats

Rehab S. Abdelrahman · Naunyn-Schmiedeberg's Archives of Pharmacology · 2017

Showing 4 of 6 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

18

Page views

0

PDF downloads

1

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.